This surface molecule has shown to be a marker of IL-17-producing cells [51], and CD161highCD8+ cells are increased in the peripheral blood of MS patients [52], therefore we wondered whether neutrophils could regulate the expression of CD161 on T cells. Here, IL17A is linked to myeloid sarcoma.